Dolby Laboratories, Inc. financial metrics

Professional SEC-based dashboard for profitability, financial health, and growth with transparent scoring logic. Latest period: Q4 2025.

Symbol
DLB on NYSE
Location
San Francisco, CA
Fiscal year end
27 September
Latest financial report
29 Jan 2026

Quick Takeaways

  • DLB - Dolby Laboratories, Inc. financial facts are built from SEC company filings data.
  • Latest metrics period on this page: Q4 2025.
  • Headline metric: Return On Equity 9.5%.

What Changed

  • Return On Equity YoY change: <span class="text-red-600">-13%</span>.
  • Most recent SEC facts end date: 26 Dec 2025.

Why This Matters

  • This gives a beginner-friendly first read before you inspect detailed formulas and metric tables.
  • Every metric card links to a deeper SEC-backed history page for verification.

Official SEC Source

Based on latest 10-Q/10-K

Facts and ratios are grounded in SEC company facts linked to the latest 10-Q/10-K cycle.

See Original Filing

Latest SEC snapshot (2025-12-26) highlights Return On Equity 9.5%, Return On Assets 5.3%, and Operating Margin 20.9%.

Financial Quality Score

Transparent 0-100 scoring model based on profitability, financial health, and growth factors.

44.7/100

Caution Confidence high

Return On Equity

9.5%

Metric score 8.6/100

Return On Assets

5.3%

Metric score 40.8/100

Financial Health

Current Ratio
3.18x
Quick Ratio
2.74x
Debt to Equity
0.02x

Strengths

Operating Margin and Debt-to-equity

Watchpoints

Return On Equity, Revenues YoY, and NetIncomeLoss YoY

Key metrics snapshot

Return On Equity

9.5%

YoY: -13%

Industry median: -5.3% (n=17)

View history

Return On Assets

5.3%

YoY: -12%

Industry median: -5.6% (n=17)

View history

Current Ratio

3.18x

YoY: +9.1%

Industry median: 1.48x (n=16)

View history

Debt-to-equity

0.02x

YoY: -4.8%

Industry median: 0.37x (n=17)

View history

NetIncomeLoss YoY

-8.4%

YoY:

Industry median: 6.4% (n=16)

View history

Profitability

Metric Latest value YoY change
Return On Equity 9.5% -13%
Return On Assets 5.3% -12%
Operating Margin 21% -11%

Financial Health

Metric Latest value YoY change
Current Ratio 3.18x +9.1%
Quick Ratio 2.74x +18%
Debt-to-equity 0.02x -4.8%

Growth

Metric Latest value YoY change
Revenues YoY 1.8%
NetIncomeLoss YoY -8.4%

Share Metrics

Metric Latest value YoY change
Weighted Average Number of Shares Outstanding, Basic 95,466,000 -0.16%
Weighted Average Number of Shares Outstanding, Diluted 96,518,000 -0.65%

Additional Metrics

Metric Latest value YoY change
Revenue from Contract with Customer, Excluding Assessed Tax $1,338,837,000 +1.8%
Cost of Revenue $162,566,000 +9%
Research and Development Expense $264,231,000 +0.37%
Selling and Marketing Expense $357,864,000 +2.3%
General and Administrative Expense $286,680,000 +4.1%
Operating Income (Loss) $247,239,000 -9.1%
Nonoperating Income (Expense) $41,797,000 -8.6%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest $289,036,000 -9%
Income Tax Expense (Benefit) $46,933,000 +12%
Earnings Per Share, Basic 2.51 -8.7%
Earnings Per Share, Diluted 2.47 -8.5%
Cash and Cash Equivalents, at Carrying Value $643,845,000 +24%
Accounts Receivable, after Allowance for Credit Loss, Current $373,091,000 +10%
Inventory, Net $31,264,000 -1.8%
Other Assets, Current $47,255,000 -5.6%
Assets, Current $1,408,062,000 +9.5%
Deferred Income Tax Assets, Net $214,346,000 -5.6%
Property, Plant and Equipment, Net $466,720,000 -2%
Operating Lease, Right-of-Use Asset $35,569,000 -3.8%
Intangible Assets, Net (Excluding Goodwill) $364,016,000 -14%
Goodwill $530,304,000 +1.9%
Other Assets, Noncurrent $88,084,000 -16%
Assets $3,192,123,000 +1.1%
Accounts Payable, Current $8,668,000 -25%
Accrued Liabilities, Current $376,212,000 +4.2%
Contract with Customer, Liability, Current $37,094,000 -0.05%
Liabilities, Current $443,507,000 +0.37%
Contract with Customer, Liability, Noncurrent $25,159,000 -23%
Operating Lease, Liability, Noncurrent $30,314,000 -8.2%
Other Liabilities, Noncurrent $90,272,000 -33%
Liabilities $589,252,000 -8.2%
Accumulated Other Comprehensive Income (Loss), Net of Tax $10,777,000 +70%
Retained Earnings (Accumulated Deficit) $2,604,358,000 +2.4%
Stockholders' Equity Attributable to Parent $2,593,675,000 +3.4%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest $2,602,871,000 +3.4%
Liabilities and Equity $3,192,123,000 +1.1%
Other Noncash Income (Expense) $1,890,000
Share-based Payment Arrangement, Noncash Expense $37,211,000 +3.2%
Increase (Decrease) in Accounts Receivable $82,956,000 +237%
Net Cash Provided by (Used in) Operating Activities $54,799,000 -49%
Net Cash Provided by (Used in) Financing Activities $121,834,000 -112%
Net Cash Provided by (Used in) Investing Activities $1,245,000
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect $65,795,000 -294%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $727,566,000 +19%
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent 0.21 0%
Operating Lease, Liability $40,639,000 -8.6%
Payments to Acquire Property, Plant, and Equipment $4,628,000 -32%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent $265,288,000 +6.7%
Lessee, Operating Lease, Liability, to be Paid $46,448,000 -13%
Property, Plant and Equipment, Gross $1,079,906,000 -1.8%
Operating Lease, Liability, Current $10,325,000 -9.6%
Lessee, Operating Lease, Liability, to be Paid, Year Two $10,005,000 +19%
Lessee, Operating Lease, Liability, to be Paid, Year One $11,107,000 -0.04%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount $5,809,000 -37%
Lessee, Operating Lease, Liability, to be Paid, Year Three $6,810,000 -12%
Unrecognized Tax Benefits $85,800,000 +1.9%
Lessee, Operating Lease, Liability, to be Paid, Year Four $3,426,000 -46%
Amortization of Intangible Assets $44,700,000 +20%
Share-based Payment Arrangement, Expense $129,655,000 +4.6%

How we score

This score is transparent and deterministic. We weight profitability, financial health, and growth metrics, then renormalize weights when SEC data is missing.

Metric Weight V1 threshold
ROIC205% to 20%
ROE158% to 25%
ROA102% to 10%
Operating Margin55% to 25%
Current Ratio121.0x to 2.0x
Quick Ratio80.8x to 1.5x
Debt to Equity100.3x to 2.0x (lower is better)
Revenue YoY10-10% to +20%
Net Income YoY10-10% to +20%

How Calculated (standard_v1)

Metrics are computed with a market-consensus convention designed for cross-portal comparability.

  • TTM Operating Income / TTM Revenues
  • Current Assets / Current Liabilities (latest instant quarter)
  • (Current Assets - Inventory) / Current Liabilities; fallback: (Cash+Short-Term Investments + Accounts Receivable) / Current Liabilities
  • Total Debt / Stockholders Equity (latest instant quarter; shared unit; freshest series)
  • TTM Net Income / Average Equity (current quarter + same quarter previous year) / 2
  • TTM Net Income / Average Assets (current quarter + same quarter previous year) / 2
  • TTM NOPAT / Average Invested Capital, where NOPAT=Operating Income*(1-tax rate), Invested Capital=Equity+Total Debt-Cash & ST Investments
  • TTM Revenues YoY
  • TTM Net Income YoY